| Dr Steven F Mciff, DDS | |
|
31 West 100 South, Suite C, Pleasant Grove, UT 84062-2641 | |
| (801) 785-0083 | |
| (801) 785-0084 |
| Full Name | Dr Steven F Mciff |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 31 West 100 South, Pleasant Grove, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831283555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 3660479922 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven F Mciff, DDS 31 West 100 South, Suite C, Pleasant Grove, UT 84062-2641 Ph: (801) 785-0083 | Dr Steven F Mciff, DDS 31 West 100 South, Suite C, Pleasant Grove, UT 84062-2641 Ph: (801) 785-0083 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
A new report says more than 100,000 American lives would be saved each year if people increased the use of five preventive services.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.
National Institutes of Health scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a New York man earlier this year.
› Verified 7 days ago
Rod P. Maxfield, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 31 W. 100 So., Suite A, Pleasant Grove, UT 84062 Phone: 801-785-2631 Fax: 801-785-7376 | |
Dr. Zachary Martineau, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1809 W State Street Suite B3, Pleasant Grove, UT 84062 Phone: 385-269-0550 | |
Larell C. Van Dyke, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 610 Loader Dr, Pleasant Grove, UT 84062 Phone: 801-785-7024 | |
Dr. Matthew Kyle Bowen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 238 E State Rd Ste 2, Pleasant Grove, UT 84062 Phone: 801-796-7779 | |
Dr. Aaron H Jones, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 597 South Pleasant Grove Boulevard, Suite 12, Pleasant Grove, UT 84062 Phone: 801-796-3535 Fax: 801-796-0303 | |
Dr. Austin Tidwell, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1082n N Northcounty Blvd, Pleasant Grove, UT 84062 Phone: 801-756-6048 | |
Gavin Trevor Smith, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 60 E State Rd, Pleasant Grove, UT 84062 Phone: 801-785-2574 |